Literature DB >> 25667782

Fracture history in osteoporosis: risk factors and its effect on quality of life.

Pınar Kuru1, Gülseren Akyüz2, Hülya Peynirci Cerşit2, Alp Eren Çelenlioğlu2, Ahmet Cumhur1, Şefikcan Biricik1, Seda Kozan1, Aylin Gökşen1, Mikail Özdemir3, Emel Lüleci3.   

Abstract

BACKGROUND: Fractures are one of the main outcomes in osteoporosis and have an important effect on the general health status. AIMS: The purpose of this study was to determine the effect of major fracture history on quality of life. We also investigated the important risk factors and their effect on bone mineral density and fracture history. STUDY
DESIGN: Cross-sectional study.
METHODS: We recruited 105 patients who were admitted to an osteoporosis outpatient clinic. Medical history, family history, calcium intake, physical activity level and biochemical tests were evaluated. Lumbar spine and femur neck bone mineral density were measured. The Qualeffo-41 questionnaire was also used for evaluating quality of life.
RESULTS: The average age of the 105 patients included in the study was 56.04±13.73 and 89% of them were post-menopausal women. The average body mass index was 26.84±5.99, which means that the women were overweight. Also, 48.5% of the patients were diagnosed with osteoporosis and 51.5% of them were diagnosed as low bone density. A total of 34 patients had a fracture history with minor trauma and some of the patients had more than one fracture (12 ankle and foot, 10 forearm, 9 vertebral, 4 hand, 3 hip, 2 rib, 1 tibial). When the patients with and without fracture history were compared, the mean Qualeffo-41 score in patients with fracture was 43.85±2.57 and in the non-fracture group was 36.27±2.01.
CONCLUSION: Forearm, ankle and foot fractures can be commonly seen in osteoporosis patients with fracture history. We suggest that it is important to recognise osteoporosis prior to first fracture and disease-specific quality of life assessment should be done.

Entities:  

Keywords:  Fracture; Qualeffo-41; post-menopausal women

Year:  2014        PMID: 25667782      PMCID: PMC4318399          DOI: 10.5152/balkanmedj.2014.13265

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  15 in total

1.  The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Authors:  J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

Review 3.  Quality of life in patients with osteoporosis.

Authors:  Paul Lips; Natasja M van Schoor
Journal:  Osteoporos Int       Date:  2004-12-18       Impact factor: 4.507

Review 4.  Diagnosis, screening, prevention, and treatment of osteoporosis.

Authors:  Karen F Mauck; Bart L Clarke
Journal:  Mayo Clin Proc       Date:  2006-05       Impact factor: 7.616

5.  The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.

Authors:  M Lunt; P Masaryk; C Scheidt-Nave; J Nijs; G Poor; H Pols; J A Falch; G Hammermeister; D M Reid; L Benevolenskaya; K Weber; J Cannata; T W O'Neill; D Felsenberg; A J Silman; J Reeve
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

6.  The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO).

Authors:  H Koçyigit; S Gülseren; A Erol; N Hizli; A Memis
Journal:  Clin Rheumatol       Date:  2003-02       Impact factor: 2.980

7.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

8.  Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  Lisa Langsetmo; Claudie Berger; Nancy Kreiger; Christopher S Kovacs; David A Hanley; Sophie A Jamal; Susan J Whiting; Jacques Genest; Suzanne N Morin; Anthony Hodsman; Jerilynn C Prior; Brian Lentle; Millan S Patel; Jacques P Brown; Tassos Anastasiades; Tanveer Towheed; Robert G Josse; Alexandra Papaioannou; Jonathan D Adachi; William D Leslie; K Shawn Davison; David Goltzman
Journal:  J Clin Endocrinol Metab       Date:  2013-05-23       Impact factor: 5.958

Review 9.  Effectiveness and safety of vitamin D in relation to bone health.

Authors:  Ann Cranney; Tanya Horsley; Siobhan O'Donnell; Hope Weiler; Lorri Puil; Daylily Ooi; Stephanie Atkinson; Leanne Ward; David Moher; David Hanley; Manchung Fang; Fatemeh Yazdi; Chantelle Garritty; Margaret Sampson; Nick Barrowman; Alex Tsertsvadze; Vasil Mamaladze
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2007-08

10.  The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women.

Authors:  Jonathan D Adachi; George Ioannidis; Wojciech P Olszynski; Jacques P Brown; David A Hanley; Rolf J Sebaldt; Annie Petrie; Alan Tenenhouse; Gregory F Stephenson; Alexandra Papaioannou; Gordon H Guyatt; Charlie H Goldsmith
Journal:  BMC Musculoskelet Disord       Date:  2002-04-22       Impact factor: 2.362

View more
  1 in total

1.  Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014.

Authors:  Yingke Xu; Qing Wu
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.